6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) mediated the expression of PD-L1 by activating NF-κB signaling in the tumor microenvironment (34). The gene discussed is PFKFB3; the disease is neoplasm.